Ledger.Open graph →
SEC Form D · filed November 17, 2020

Apertor Pharmaceuticals, Inc

Offering
$50.0M
Sold
$3.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Edmund Graziani · New York, NYExec · DirectorRobert T. Abraham · New York, NYDirectorPaul Eisenberg · New York, NYDirectorSeth Harrison · Cambridge, MADirectorSpiros Liras · New York, NYExec · DirectorEdmund Graziani · New York, NYExec · DirectorRobert T. Abraham · New York, NYDirectorPaul Eisenberg · New York, NYDirectorSeth Harrison · New York, NYDirectorSpiros Liras · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗